Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
Precision Drilling
PDS
US Stock MarketDetailed Quotes
NSPR InspireMD
- 2.940
- -0.040-1.34%
Trading Dec 20 15:02 ET
76.69MMarket Cap-4.14P/E (TTM)
2.960High2.820Low7.13KVolume2.880Open2.980Pre Close20.66KTurnover0.05%Turnover RatioLossP/E (Static)26.08MShares3.42052wk High1.85P/B44.28MFloat Cap1.81052wk Low--Dividend TTM15.06MShs Float75862432.808Historical High--Div YieldTTM4.70%Amplitude0.806Historical Low2.896Avg Price1Lot Size
About InspireMD Company
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.
Company Profile
SymbolNSPR
Company NameInspireMD
Listing DateMar 1, 2010
Founded2005
CEOMr. Marvin Slosman
MarketNASDAQ
Employees66
Fiscal Year Ends12-31
Address6303 Waterford District Drive,Suite 215
CityMiami
ProvinceFlorida
CountryUnited States of America
Zip Code33126
Websitehttp://www.inspiremd.com
Company Executives
- Name
- Position
- Salary
- Marvin Slosman
- Director, President and Chief Executive Officer
- 3.22M
- Shane T. Gleason
- Chief Commercial Officer
- 1.11M
- Andrea Tommasoli
- Chief Operating Officer
- --
- Craig Shore
- Chief Financial Officer, Principal Accounting Officer, Chief Administrative Officer, Secretary and Treasurer
- 1.80M
- Patrick Verta
- Executive Vice President, Clinical and Medical Affairs
- --
- Paul S. Stuka
- Non-Executive Chairman of the Board
- 574.93K
- Scott R. Ward
- Director
- --
- Kathryn Arnold
- Independent Director
- 375.25K
- Michael Berman
- Independent Director
- 380.25K
- Dr. Gary S. Roubin, M.D.,PhD
- Independent Director
- 374.25K
- Thomas J. Kester
- Independent Director
- 385.25K